Dr. Reddy's Laboratories Limited RDY
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -55.47% | -44.31% | -26.64% | 1.37% | 6.56% |
| Total Depreciation and Amortization | 4.24% | 10.65% | 15.57% | 15.98% | 21.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 349.50% | -23.01% | 68.27% | 957.93% | -11.71% |
| Change in Net Operating Assets | -4.72% | 43.15% | 61.69% | 47.36% | 45.45% |
| Cash from Operations | -50.29% | -24.83% | 17.82% | 68.75% | 66.83% |
| Capital Expenditure | 40.64% | 35.75% | 18.49% | -1.41% | -20.45% |
| Sale of Property, Plant, and Equipment | 336.52% | 67.54% | -43.38% | -76.26% | -76.10% |
| Cash Acquisitions | -92.35% | 94.19% | 94.56% | 96.89% | 96.89% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.83% | -173.63% | -268.10% | -219.73% | -462.09% |
| Cash from Investing | 42.07% | 29.32% | -7.25% | 10.26% | 31.14% |
| Total Debt Issued | 4,596.68% | 44.25% | -17.28% | -77.31% | -101.18% |
| Total Debt Repaid | -456.76% | -412.05% | 2.32% | 15.38% | -269.74% |
| Issuance of Common Stock | 31.17% | 21.35% | 105.70% | 54.46% | 64.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 8.59% | 4.10% | 4.10% | 4.10% | 4.10% |
| Other Financing Activities | -21.83% | -252.55% | -224.29% | -208.04% | -197.76% |
| Cash from Financing | 106.36% | -72.20% | -61.05% | -123.68% | -142.06% |
| Foreign Exchange rate Adjustments | 43.82% | 175.80% | 438.79% | 1,309.01% | 543.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 339.86% | -42.38% | -91.74% | -6.14% | 40.79% |